Growth hormone release after desipramine in depressive illness.
The effect of i.m. administration of 75 mg of desipramine on growth hormone (GH) secretion was investigated in a sample of 87 patients with major depressive disorders and in 31 normal controls. The GH response was lower in depressed females compared to depressed males, but no such difference was present in controls. In the premenopausal female group, GH response was significantly lower in depressed patients than in controls. No significant difference was found between normal males and male depressed patients. In the premenopausal group, no difference emerged between endogenous and nonendogenous depressed women.
D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000097:blood; D003866:Depressive Disorder / Q000097:blood* / Q000175:diagnosis; D003891:Desipramine / Q000097:blood*; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay; D012737:Sex Factors
D013006:Growth Hormone; D003891:Desipramine